Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors

NCT02415153 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02415153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02415153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Trial of Pomalidomide for Children With Recurrent, Progressive, or Refractory CNS Tumors
Lead sponsor
National Cancer Institute (NCI)
Phase
Phase 1
Overall status
Completed
Start date
July 14, 2015
Completion date
May 27, 2020
Enrollment
29 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

neurofibromatosis type 1, recurrent childhood brain stem glioma, recurrent childhood visual pathway glioma, recurrent primary central nervous system neoplasm, refractory primary central nervous system neoplasm